David Roman analyst

Currently out of the existing stock ratings of David Roman, 8 are a BUY (32%), 12 are a HOLD (48%), 5 are a SELL (20%).

David Roman

Work Performance Price Targets & Ratings Chart

Analyst David Roman, currently employed carries an average stock price target met ratio of 90.48% that have a potential upside of 18.49% achieved within 411 days. Previously, David Roman worked at GOLDMAN SACHS.

David Roman’s has documented 54 price targets and ratings displayed on 7 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on ISRG, Intuitive Surgical at 30-May-2024.

Wall Street Analyst David Roman

Analyst best performing recommendations are on VAR (VARIAN MEDICAL SYSTEMS).
The best stock recommendation documented was for VAR (VARIAN MEDICAL SYSTEMS) at 9/28/2015. The price target of $66.64 was fulfilled within 7 days with a profit of $3.99 (6.37%) receiving and performance score of 9.1.

Average potential price target upside

BAX Baxter International ISRG Intuitive Surgical NUVA NuVasive MDT Medtronic PLC HAE Haemonetics VAR Varian Medical Systems SYK Stryker

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$38

$4.79 (14.42%)

$50

13 days ago
(11-Nov-2024)

1/9 (11.11%)

$3.89 (11.40%)

218

Hold

$40

$6.79 (20.45%)

$38

1 months 23 days ago
(01-Oct-2024)

6/16 (37.5%)

$3.09 (8.37%)

191

Hold

$42

$8.79 (26.47%)

$44

3 months 17 days ago
(07-Aug-2024)

2/13 (15.38%)

$5.41 (14.79%)

151

Buy

$45

$11.79 (35.50%)

$53

4 months 22 days ago
(02-Jul-2024)

7/11 (63.64%)

$12.15 (36.99%)

316

Hold

$40

$6.79 (20.45%)

$40

6 months 14 days ago
(10-May-2024)

9/16 (56.25%)

$4.62 (13.06%)

225

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is David Roman is most bullish on?

Potential upside of $-12.85 has been obtained for SYK (STRYKER)

Which stock is David Roman is most reserved on?

Potential downside of -$47.87 has been obtained for ISRG (INTUITIVE SURGICAL)

What Year was the first public recommendation made by David Roman?

On 2012

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?